PMID: 3234632Nov 1, 1988Paper

Impairment of diastolic function in middle-aged type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients free of cardiovascular disease

Diabetologia
M UusitupaK Pyörälä

Abstract

Left ventricular systolic and diastolic function was studied using systolic time intervals and echocardiography in 19 male and 17 female patients with Type 1 (insulin-dependent) diabetes, 24 male and 15 female patients with Type 2 (non-insulin-dependent) diabetes and 24 male and 24 female control subjects. The subjects for the present study were selected from a population based study in which 117 Type 1 and 510 Type 2 diabetic patients and 649 non-diabetic subjects were originally examined. After exclusions, none of the subjects had any evidence of coronary heart disease, hypertension or other diseases known to affect left ventricular function. There were no consistent differences in systolic time intervals or echocardiographic variables of systolic function between patients with Type 1 diabetes and non-diabetic control subjects; but patients with Type 2 diabetes showed an increased fractional shortening. Female patients with Type 2 diabetes showed an increased left ventricular mass not explicable by hypertension. Isovolumic relaxation period was longer in male (86 +/- 3 ms; mean +/- SEM) and female patients (84 +/- 6 ms) with Type 2 diabetes than in male (76 +/- 3 ms; p less than 0.05) and female (71 +/- 3 ms; p less than 0.05...Continue Reading

Citations

Feb 1, 1994·Cardiovascular Drugs and Therapy·F S Fein, E H Sonnenblick
Jun 1, 1996·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·M MäntysaariM Uusitupa
Sep 18, 1991·Molecular and Cellular Biochemistry·S W Schaffer
Jun 15, 1994·The American Journal of Cardiology·J N MustonenK Pyörälä
Jul 1, 1995·Journal of Diabetes and Its Complications·O R WirtaY E Lähde
Apr 8, 1999·Journal of the American College of Cardiology·Y MomiyamaM Kimura
Sep 12, 2003·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A AkulaJ P Gomedhikam
Jun 1, 1993·Journal of Internal Medicine·M Uusitupa, E Vanninen
Sep 1, 1994·Journal of Internal Medicine·L NiskanenM Uusitupa
Jul 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·B M Fisher, B M Frier
Feb 15, 2001·Echocardiography·Bertil AndrénHans Lithell
Oct 1, 1990·British Heart Journal·M J SampsonP L Drury
Nov 9, 2010·Vascular Health and Risk Management·Christina VoulgariNicholas Tentolouris
Dec 27, 2005·The American Journal of Cardiology·Anna M GrandiAchille Venco
Aug 1, 1992·The American Journal of Cardiology·E VanninenM Uusitupa
Jan 1, 1990·Diabetes Research and Clinical Practice·S FerraroE Marmo
Nov 1, 1989·Diabetic Medicine : a Journal of the British Diabetic Association·B M FisherB M Frier
Feb 28, 2001·Diabetes, Obesity & Metabolism·R Donnelly, K R Davis
Jul 1, 1993·Applied Microbiology and Biotechnology·G GossetF Bolivar
Dec 1, 1990·Annals of Medicine·M I UusitupaK E Airaksinen
Aug 16, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Ellen AasumTerje S Larsen
Sep 3, 2004·Clinical Science·Sajad A HayatRayaz A Malik

❮ Previous
Next ❯

Related Concepts

Related Feeds

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.